US Patent 9463208 Bacteriotherapy for clostridium difficile colitis
Patent 9463208 was granted and assigned to Rebiotix on October, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 2, 2013
0
Date of Patent
October 11, 2016
0
Patent Applicant
Patent Application Number
14093913
0
Patent Citations Received
Patent Inventor Names
Edwin J. Hlavka
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9463208 Bacteriotherapy for clostridium difficile colitis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.